摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

三甲基十四烷基铵硫酸甲酯盐 | 65059-43-0

中文名称
三甲基十四烷基铵硫酸甲酯盐
中文别名
——
英文名称
1-Tetradecanaminium, N,N,N-trimethyl-, methyl sulfate
英文别名
methyl sulfate;trimethyl(tetradecyl)azanium
三甲基十四烷基铵硫酸甲酯盐化学式
CAS
65059-43-0
化学式
C18H41NO4S
mdl
——
分子量
367.6
InChiKey
VXBSKVAMQMBCCA-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.49
  • 重原子数:
    24
  • 可旋转键数:
    13
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    74.8
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2923900090

文献信息

  • FLUORESCENCE DETECTION OF POISON OAK OIL
    申请人:The Regents of the University of California
    公开号:US20130121924A1
    公开(公告)日:2013-05-16
    The invention herein disclosed provides for compositions, methods for synthesizing said compositions, and methods for using said compositions, wherein the compositions and methods may be used to bind to and/or deactivate a poison oak oil, such as urushiol. The compositions and methods can be used to treat and/or reduce an inflammatory reaction and/or hypersensitivity to natural compounds found in poison oak, poison ivy, poison sumac, mango, lac tree, and cashew nut.
    本公开的发明提供了用于合成所述组合物的方法,以及使用所述组合物的方法,其中这些组合物和方法可用于结合和/或使毒橡树油(如漆酚)失活。这些组合物和方法可用于治疗和/或减轻对毒橡树、毒藤、毒漆树、芒果、漆树和腰果中发现的天然化合物的炎症反应和/或过敏反应。
  • COMPOSITIONS COMPRISING LIPOXYGENASE INHIBITORS AND CYCLODEXTRIN
    申请人:Kipp E. James
    公开号:US20070111965A1
    公开(公告)日:2007-05-17
    The present invention is directed to formulations of inclusion complexes of lipoxygenase inhibitors and cyclodextrins having a therapeutically effective concentration of the lipoxygenase inhibitor, methods of making the same and methods of treating disease states using the same. Forming cyclodextrin complexes permits the enhancement of the aqueous solubility of lipoxygenase inhibitors which allows higher concentrations of the lipoxygenase in solution. Aqueous formulations of lipoxygenase inhibitors-cyclodextrin complexes are suitable for parenteral or oral administration for treating and/or preventing inflammatory disease states. The aqueous formulations can be lyophilized to prolong storage stability, assist in oral administration and/or provide for convenient and economical packaging.
    本发明涉及含脂氧化酶抑制剂和环糊精的包含物复合物的配方,具有治疗有效浓度的脂氧化酶抑制剂,制备方法以及使用它们治疗疾病状态的方法。形成环糊精复合物可以增强脂氧化酶抑制剂的水溶性,从而允许在溶液中获得更高浓度的脂氧化酶。脂氧化酶抑制剂-环糊精复合物的水溶性配方适用于静脉或口服给药,用于治疗和/或预防炎症性疾病状态。水溶性配方可以冻干以延长储存稳定性,帮助口服给药和/或提供方便和经济的包装。
  • COMPOSITIONS OF LIPOXYGENASE INHIBITORS
    申请人:Kipp E. James
    公开号:US20070134341A1
    公开(公告)日:2007-06-14
    Pharmaceutical compositions comprising particles of lipoxygenase inhibitor compounds having an effective average size of from about 10 nm to about 50 microns are provided. More particularly, pharmaceutical compositions of particle of a 5-lipoxygenase inhibitor compound having an effective average size of from about 50 nm to about 5 microns are provided. The pharmaceutical compositions are in the form of aqueous suspensions with the particle of the 5-lipoxygenase inhibitor compound present in concentrations of from about 5 to about 200 mg/ml. In addition, methods for making such pharmaceutical compositions are provided. In particular, microprecipitation and direct homogenization in the presence of at least one surfactant are disclosed for making the pharmaceutical compositions.
    提供了包含脂氧合酶抑制剂化合物颗粒的制药组合物,其有效平均尺寸从大约10纳米到大约50微米。更具体地,提供了有效平均尺寸从大约50纳米到大约5微米的5-脂氧合酶抑制剂化合物颗粒的制药组合物。这些制药组合物以水悬浮液的形式存在,其中5-脂氧合酶抑制剂化合物的颗粒浓度为大约5到200毫克/毫升。此外,还提供了制备这种制药组合物的方法。具体来说,揭示了使用至少一种表面活性剂进行微相沉淀和直接均质化制备制药组合物的方法。
  • Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
    申请人:Babul Najib
    公开号:US20120065221A1
    公开(公告)日:2012-03-15
    The present invention is directed to oral, therapeutically effective extended release pharmaceutical compositions of 3-hydroxy-N-methylmorphinan, including delayed onset, extended release dosage forms and the use thereof.
    本发明涉及口服、治疗有效的3-羟基-N-甲基吗啡酮的延迟作用、延长释放药物组成物,包括延迟起效、延长释放剂型及其使用。
  • Peroxygen bleach activators and bleaching compositions
    申请人:THE PROCTER & GAMBLE COMPANY
    公开号:EP0150532A1
    公开(公告)日:1985-08-07
    This invention relates to peroxygen bleaching activator compounds and bleaching compositions. The peroxygen bleach activator compounds, used in combination with peroxygen bleach compounds which yield hydrogen peroxide in an aqueous solution, provide effective and efficient bleaching of textiles over a wide range of temperatures. In a highly preferred embodiment the bleaching compositions of the invention are detergent compositions. The method of preparing these peroxygen bleach activator compounds is also claimed.
    本发明涉及过氧漂白活化剂化合物和漂白组合物。过氧漂白活化剂化合物与在水溶液中产生过氧化氢的过氧漂白化合物结合使用,可在很宽的温度范围内对纺织品进行有效和高效的漂白。在一个非常优选的实施方案中,本发明的漂白组合物是洗涤剂组合物。本发明还提出了制备这些过氧漂白活化剂化合物的方法。
查看更多